| Overview |
| bsm-62012r |
| IRF9/ISGF3 Recombinant Antibody |
| WB, Flow-Cyt, ICC/IF |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Interferon regulatory factor 9 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 10379 |
| Q00978 |
| Irf9; ISGF3; ISGF3G; p48. |
| Transcription regulatory factor that mediates signaling by type I IFNs (IFN-alpha and IFN-beta). Following type I IFN binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. |
| Application Dilution |
| WB |
1:300-5000 |
| Flow-Cyt |
FCM1:20-100 |
| ICC/IF |
IFICC1:50-200 |